Cargando…
Expression of Programmed Death-Ligand 1 in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed and Nonsun-Exposed Skin
BACKGROUND: A recent clinical trial has shown the efficacy of an anti-programmed death-1 (PD-1) antibody against advanced squamous cell carcinoma (SCC). The expression of PD-ligand 1 (PD-L1) in tumor cells correlates with a favorable response to anti-PD-1 therapy in various malignancies. In recent s...
Autores principales: | Goto, Hiroyuki, Sugita, Kazunari, Yamamoto, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810068/ https://www.ncbi.nlm.nih.gov/pubmed/33487707 http://dx.doi.org/10.4103/ijd.IJD_187_19 |
Ejemplares similares
-
Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
por: Goto, Hiroyuki, et al.
Publicado: (2021) -
Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study
por: Morelló-Vicente, Ana, et al.
Publicado: (2023) -
Spatial epidemiology of skin cancer in Iran: separating sun-exposed and non-sun-exposed parts of the body
por: Kiani, Behzad, et al.
Publicado: (2022) -
Post‐kidney transplant cancers: Racial and ethnic differences in sun‐exposed skin versus non‐sun‐exposed anogenital skin
por: Takeda, Kotaro, et al.
Publicado: (2022) -
Adult-onset Still’s Disease Secondary to Cytophagic Histiocytic Panniculitis
por: YOSHIDA, Ai, et al.
Publicado: (2022)